Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAIL: Allogeneic MSCs for No-option Ischemic Limbs
NCT03042572Phase 3Unknown
- Start
- Dec 2018
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic bone marrow-derived mesenchymal stromal cells in Peripheral Arterial Disease (PAD), critical limb ischemia (CLI). Status: unknown.
02
Drugs
allogeneic bone marrow-derived mesenchymal stromal cells
03
Conditions
Peripheral Arterial Disease (PAD)critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT03042572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03042572.